Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
10x Genomics (TXG) has shared an update.
Adam S. Taich is set to become the new Chief Financial Officer of the Company on August 12, 2024, bringing a wealth of experience from his previous roles at Standard BioTools Inc., SomaLogic, Inc., and ThermoFisher Scientific. He succeeds Justin J. McAnear, who will assist in the transition until August 30. Taich’s compensation package includes a $500,000 annual salary, potential bonuses, stock unit grants, and standard executive benefits. The Company has confirmed there are no undisclosed arrangements or conflicts of interest associated with Taich’s appointment.
For an in-depth examination of TXG stock, go to TipRanks’ Stock Analysis page.
